BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36484824)

  • 1. Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4.
    Martins DOS; Souza RAC; Freire MCLC; de Moraes Roso Mesquita NC; Santos IA; de Oliveira DM; Junior NN; de Paiva REF; Harris M; Oliveira CG; Oliva G; Jardim ACG
    J Biol Inorg Chem; 2023 Feb; 28(1):101-115. PubMed ID: 36484824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
    Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
    Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragmentation Study, Dual Anti-Bactericidal and Anti-Viral Effects and Molecular Docking of Cobalt(III) Complexes.
    Fernandes LP; Silva JMB; Martins DOS; Santiago MB; Martins CHG; Jardim ACG; Oliveira GS; Pivatto M; Souza RAC; Franca EF; Deflon VM; Machado AEH; Oliveira CG
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
    Dutta SK; Sengupta S; Tripathi A
    In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
    Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
    Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.
    Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D
    FEBS J; 2024 Jun; 291(12):2656-2673. PubMed ID: 38303163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing potential of rimantadine hydrochloride and development of a promising platinum(II)-rimantadine metallodrug for the treatment of Chikungunya virus infection.
    Santos IA; Pereira AKDS; Guevara-Vega M; de Paiva REF; Sabino-Silva R; Bergamini FRG; Corbi PP; Jardim ACG
    Acta Trop; 2022 Mar; 227():106300. PubMed ID: 34979144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
    Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
    J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chaudhary M; Sehgal D
    J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
    Issac TH; Tan EL; Chu JJ
    J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication.
    Rasool N; Bakht A; Hussain W
    Curr Drug Discov Technol; 2021; 18(3):437-450. PubMed ID: 32164512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya virus requires cellular chloride channels for efficient genome replication.
    Müller M; Slivinski N; Todd EJAA; Khalid H; Li R; Karwatka M; Merits A; Mankouri J; Tuplin A
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007703. PubMed ID: 31483794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing approach against chikungunya virus: an
    Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S
    Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate.
    Freire MCLC; Basso LGM; Mendes LFS; Mesquita NCMR; Mottin M; Fernandes RS; Policastro LR; Godoy AS; Santos IA; Ruiz UEA; Caruso IP; Sousa BKP; Jardim ACG; Almeida FCL; Gil LHVG; Andrade CH; Oliva G
    Sci Rep; 2022 Jun; 12(1):10601. PubMed ID: 35732685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo.
    Rathore AP; Haystead T; Das PK; Merits A; Ng ML; Vasudevan SG
    Antiviral Res; 2014 Mar; 103():7-16. PubMed ID: 24388965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.